Researchers in Dr. Bingwei Lu's lab have identified genes that could serve as therapeutic targets for the treatment of Parkinson's disease (PD). PD is a common neurodegenerative movement disorder affecting 1% of the population over the age 60.
Stanford and Rockefeller researchers have identified and developed dynein-specific inhibitors that have significant medical applications involving mitotic spindle assembly, organelle transport, and primary cilia formation.
Researchers in Dr. Or Gozani's laboratory have produced lysine methyltransferases, histone octomers, purified nucleosomes, and antibodies for use in chromatin and epigenetic research.
Researchers in Dr. Michael Cleary's laboratory at Stanford University have developed a highly specific monoclonal antibody for AF5, a proto-oncoprotein associated with pediatric and adult acute leukemia.
Researchers in the laboratories of Dr. Eric Kool and Dr. Howard Chang have created and characterized chemical probes that enable accurate RNA structural analysis in living cells. RNA structure plays an important role in practically every facet of gene regulation.
A method of using neuregulin antagonists to delay the time of tumor recurrence in cancer patients has been developed by Dr. Sweet-Cordero and collaborators. This technology is available for non-exclusive license.
Researchers in Dr. Laura Attardi's lab have created a knock-in mouse strain which generates a form of p53 that is not subject to degradation by the proteasome.
Researchers in Dr. Roeland Nusse's laboratory have generated an Axin2CreERT2 knock-in mouse strain that can be used to identify and map stem cells in any tissue. The Wnt/β-catenin signaling pathway is instrumental for stem cell maintenance in multiple tissues.
Engineers in the Stanford Microfluidics Laboratory have developed a sensitive, high-resolution, label-free detection method for identifying and quantifying analytes on chip-based electrophoretic assays.
Hemizygous mice are viable and fertile with no anatomic abnormalities. Transgene expression is observed in aorta, heart, and brain. Transgenicdimethylarginine dimethylaminohydrolase (DDAH) activity is reflected in a reduction of plasma asymmetric dimethylarginine (ADMA).
Researchers in Prof. Juan Santiago's laboratory have developed a novel isotachophoresis (ITP) method to easily and seamlessly integrate various electrophoresis-based detection techniques with ITP preconcentration.
This invention enables the high-sensitivity, high-resolution stacking, separation, and fluorescence-based detection of non-fluorescent analytes in any electrophoresis platform.
Stanford researchers have developed a versatile computational approach for easily visualizing and analyzing multidimensional molecular data, such as flow cytometry data.
Stanford researchers have patented an in vitro system for the detection and quantification of basophils. The technology can be used to identify and monitor patients with immune system disorders - such as anaphylaxis, myeloproliferative disorders, or infections.